This session discusses treatment strategies and clinical indications for the superficial femoral and popliteal arteries. This distribution of peripheral vascular disease offers a number of treatment alternatives which have impact on cost, reimbursement and both long and short term patency. The rapidly evolving technology being developed and currently in use will be discussed.

This activity is designed to meet the educational needs of interventional radiologists and other physicians at all levels with special interest in infra-inguinal disease.

Learning Objectives
Upon completion of this enduring activity, participants should be able to:

• Discuss treatment strategies and clinical indications for the superficial femoral and popliteal arteries
• Explain the treatment alternatives and how they may have impact on cost, reimbursement and both long and short term patency
• Describe the rapidly evolving technology that is currently in use and those being developed

Faculty
Coordinator
Michael J. Miller, Jr., MD, Duke University Medical Center

Speakers
Bjorn I. Engstrom, MD
Charles Gilliland, MD, Emory University School of Medicine
Mark L. Lessne, MD, Vascular & Interventional Specialists of Charlotte Radiology
Shawn Sarin, MD, FSIR, George Washington University
Robert A. Lookstein, MD, FSIR, Mount Sinai Hospital